Dr. Ozlem Goker-Alpan, MD
Claim this profileLDRTC
Studies Gaucher Disease
Studies Fabry Disease
18 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Ozlem Goker-Alpan, MD is currently running
Venglustat vs Imiglucerase
for Gaucher Disease
This trial compares a pill to injections in patients aged 12-18 and adults with Gaucher disease Type 3. The pill aims to help with brain symptoms, while the injections maintain overall health. The pill has the potential to improve Gaucher disease by rebalancing certain substances in the body.
Recruiting2 awards Phase 310 criteria
FLT201
for Gaucher Disease
This is a multicenter, long-term, follow-up trial of participants with Gaucher disease type 1 who received FLT201 treatment in a preceding clinical trial. Participants will be followed for 5 years post-treatment.
Recruiting1 award Phase 1 & 2
More about Ozlem Goker-Alpan, MD
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Ozlem Goker-Alpan, MD has experience with
- FLT201
- ST-920
- 4D-310
- Biomarkers
- Α-Synuclein
- LRRK2
Breakdown of trials Ozlem Goker-Alpan, MD has run
Gaucher Disease
Fabry Disease
Lysosomal Storage Diseases
Mucopolysaccharidosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ozlem Goker-Alpan, MD specialize in?
Ozlem Goker-Alpan, MD focuses on Gaucher Disease and Fabry Disease. In particular, much of their work with Gaucher Disease has involved GCase enzyme activity positive patients, or patients who are undergoing treatment.
Is Ozlem Goker-Alpan, MD currently recruiting for clinical trials?
Yes, Ozlem Goker-Alpan, MD is currently recruiting for 3 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Ozlem Goker-Alpan, MD has studied deeply?
Yes, Ozlem Goker-Alpan, MD has studied treatments such as FLT201, ST-920, 4D-310.
What is the best way to schedule an appointment with Ozlem Goker-Alpan, MD?
Apply for one of the trials that Ozlem Goker-Alpan, MD is conducting.
What is the office address of Ozlem Goker-Alpan, MD?
The office of Ozlem Goker-Alpan, MD is located at: LDRTC, Fairfax, Virginia 22030 United States. This is the address for their practice at the LDRTC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.